# The 1st Tumor CytokinoTherapy Database (TCTD-1)

> **NCT06222801** · — · RECRUITING · sponsor: **OncoCareClinic 308 Ltd** · enrollment: 5000 (estimated)

## Conditions studied

- Oncology

## Interventions

- **DRUG:** Tumor necrosis factor alpha
- **DRUG:** Interferon gamma

## Key facts

- **NCT ID:** NCT06222801
- **Lead sponsor:** OncoCareClinic 308 Ltd
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-19
- **Primary completion:** 2032-09-01
- **Final completion:** 2032-12-01
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2024-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06222801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06222801, "The 1st Tumor CytokinoTherapy Database (TCTD-1)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06222801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*